Palisade Bio (PALI) Other Accumulated Expenses (2012 - 2026)

Palisade Bio (PALI) has 15 years of Other Accumulated Expenses data on file, last reported at $219000.0 in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $219000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $219000.0 (changed N/A YoY), and the FY2025 annual result was $433000.0, up 448.1% from the prior year.
• Other Accumulated Expenses fell to $219000.0 in Q1 2026 per PALI's latest filing, from $433000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $433000.0 in Q4 2025 and troughed at $11000.0 in Q2 2022.
• A 5-year average of $156857.1 and a median of $180000.0 in 2023 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses plunged 86.25% in 2022, then soared 775.0% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $88000.0 in 2022, then soared by 106.82% to $182000.0 in 2023, then sank by 56.59% to $79000.0 in 2024, then soared by 448.1% to $433000.0 in 2025, then sank by 49.42% to $219000.0 in 2026.
• Business Quant data shows PALI's Other Accumulated Expenses at $219000.0 in Q1 2026, $433000.0 in Q4 2025, and $202000.0 in Q3 2025.